Global Multiple Sclerosis Treatment Market Size To Grow At A CAGR Of 6% In The Forecast Period Of 2023-2031
5 mins read

Global Multiple Sclerosis Treatment Market Size To Grow At A CAGR Of 6% In The Forecast Period Of 2023-2031

The ‘Multiple Sclerosis Treatment Global Market Share, Size, Price, Trends, Growth, Report and Forecast 2023-2031′ by Expert Market Research provides a comprehensive outlook of the global multiple sclerosis treatment market, assessing the market based on its segments like indication type, diagnosis type, treatment type, end user, and major regions.

The report also offers a detailed insight into the market through patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, and partnerships and collaborations analysis.

Multiple Sclerosis Treatment Market Size, Share, Price, Trends, Growth, Key Players, Report and Forecast

The key highlights of the report include:

Market Overview (2016-2031)

  • Forecast CAGR (2023-2031): 6%

The growing awareness of multiple sclerosis and the increasing number of drugs in clinical trials by leading pharmaceutical companies are expected to drive the growth of the global multiple sclerosis treatment market. However, the high cost of treatment and limited availability of effective therapies may pose challenges to market growth.

Get a Free Sample Report with Table of Contents –

Advancements in diagnostic tools and the development of innovative treatment options are expected to have a positive impact on the global multiple sclerosis treatment market growth. Over the forecast period, the anticipated increase in the development of various drugs and therapies, along with the growing demand for personalized medicine and strengthening healthcare infrastructure, are likely to contribute to market growth.

Multiple Sclerosis Treatment Industry Definition and Major Segments

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system. It occurs when the immune system mistakenly attacks the myelin sheath covering nerve fibres, causing communication problems between the brain and the rest of the body. Treatment options include disease-modifying therapies, symptom management, and rehabilitation.

Read Full Report with Table of Contents –

Based on indication type, the market is segmented into:

  • Clinically Isolated Syndrome (CIS)
  • Relapse-remitting MS (RRMS)
  • Primary Progressive MS (PPMS)
  • Secondary Progressive MS (SPMS)

Based on the diagnosis methods, the market is classified into:

  • Blood and Imaging Tests
  • Spinal Tap (Lumbar Puncture)
  • Magnetic Resonance Imaging
  • Evoked Potential Tests
  • Others

Based on the treatment methods, the market is classified into:

  • Corticosteroids
  • Plasma Exchange (Plasmapheresis)
  • Injectable Treatments
    • Interferon Beta Medications
    • Glatiramer Acetate
  • Oral Treatments
    • Fingolimod
    • Dimethyl fumarate
    • Siponimod
  • Infusion Treatments
    • Ocrelizumab
    • Natalizumab
    • Alemtuzumab

Based on end user, the market is bifurcated into:

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Based on region, the market is segregated into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Multiple Sclerosis Treatment Market Trends

The key trends in the global multiple sclerosis treatment market include the growing research and development efforts by the healthcare sector, aimed at the development of new drug combinations and therapies to combat the disease. Additionally, advancements in diagnostic tools, such as magnetic resonance imaging (MRI) and cerebrospinal fluid analysis, are expected to contribute to market growth.

Increased clinical trials with novel therapies, such as stem cell transplantation and neuroprotective agents, are projected to boost market growth. Furthermore, the development of digital tools and wearable devices to monitor and manage multiple sclerosis symptoms is expected to impact the growth of the market positively.

Key Market Players

The major players in the global multiple sclerosis treatment market report are:

  • Opexa Therapeutics, Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Actelion Pharmaceuticals Ltd.
  • GSK plc
  • Novartis AG
  • Johnson & Johnson
  • AstraZeneca plc
  • Merck KGaA
  • Abbott Laboratories

The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.

The report studies the latest updates in the market, along with their impact across the market. It also analyzes the market demand, together with its price and demand indicators. The report also tracks the market based on SWOT and Porter’s Five Forces Models.

Related Reports:

Geofencing Market:

ISO Tank Container Market:

Garlic Market:

Hardware Wallet Market:

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact:

Company Name: Claight Corporation
Contact Person: Anisha Luccas, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA